Beth C. Seidenberg Buys 46,875 Shares of Sagimet Biosciences Inc. Series A (NASDAQ:SGMT) Stock
Sagimet Biosciences Inc. Series A (NASDAQ:SGMT – Get Free Report) Director Beth C. Seidenberg acquired 46,875 shares of the company’s stock in a transaction dated Tuesday, July 18th. The shares were bought at an average price of $16.00 per share, for a total transaction of $750,000.00. Following the acquisition, the director now owns 46,875 shares […]